We are live on ! Find out more
AP

Arlington Partners Portfolio holdings

AUM $55.4M
1-Year Est. Return 8%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+8%
3 Year Est. Return
+43.69%
5 Year Est. Return
+33.63%
10 Year Est. Return
AUM
$353M
AUM Growth
-$18.9M
Cap. Flow
-$6.28M
Cap. Flow %
-1.78%
Top 10 Hldgs %
57.56%
Holding
697
New
19
Increased
50
Reduced
149
Closed
246

Sector Composition

Rank Sector Weight
1 Technology 9.11%
2 Financials 6.36%
3 Healthcare 5.12%
4 Industrials 4.44%
5 Communication Services 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEE icon
451
Ameren
AEE
$30.4B
-39
Closed -$3K
AES icon
452
AES
AES
$10.6B
-416
Closed -$10K
AFRM icon
453
Affirm
AFRM
$23.5B
-78
Closed -$8K
AIG icon
454
American International
AIG
$42.5B
-214
Closed -$12K
ALL icon
455
Allstate
ALL
$70.6B
-70
Closed -$8K
AMBA icon
456
Ambarella
AMBA
$3.04B
-49
Closed -$10K
ANET icon
457
Arista Networks
ANET
$199B
-80
Closed -$3K
AOS icon
458
A.O. Smith
AOS
$8.55B
-79
Closed -$7K
APTV icon
459
Aptiv
APTV
$12.3B
-20
Closed -$3K
ARE icon
460
Alexandria Real Estate Equities
ARE
$9.37B
-15
Closed -$3K
ARGX icon
461
argenx
ARGX
$55.2B
-10
Closed -$4K
ATMP icon
462
iPath Select MLP ETN
ATMP
$635M
-3,804
Closed -$59K
AXS icon
463
AXIS Capital
AXS
$7.81B
-475
Closed -$26K
BBY icon
464
Best Buy
BBY
$19B
-50
Closed -$5K
BCS icon
465
Barclays
BCS
$87.8B
-254
Closed -$3K
BF.B icon
466
Brown-Forman Class B
BF.B
$13.5B
-112
Closed -$8K
BFH icon
467
Bread Financial
BFH
$4.32B
-58
Closed -$4K
BIO icon
468
Bio-Rad Laboratories Class A
BIO
$8.76B
-3
Closed -$2K
BSX icon
469
Boston Scientific
BSX
$68.4B
-181
Closed -$8K
BTI icon
470
British American Tobacco
BTI
$136B
-349
Closed -$13K
BUD icon
471
AB InBev
BUD
$164B
-199
Closed -$12K
BXP icon
472
Boston Properties
BXP
$11.6B
-18
Closed -$2K
C icon
473
Citigroup
C
$213B
-750
Closed -$45K
CBSH icon
474
Commerce Bancshares
CBSH
$8.68B
-7
Closed
CCEP icon
475
Coca-Cola Europacific Partners
CCEP
$49.1B
-85
Closed -$5K

Similar funds

Arlington Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Arlington Partners held 697 positions worth $353M, down 5.1% from $372M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Arlington Partners's Q1 2022 filing shows 19 new, 50 increased, 149 reduced and 246 closed positions. Its largest new stake was Fulgent Genetics: 200 shares worth $12K. The largest sale was iShares Emerging Markets Dividend ETF, an estimated $8.36M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.

  • Arlington Partners's largest Q1 2022 buy was Fulgent Genetics: 200 shares worth $12K.
  • Arlington Partners added most to Vanguard FTSE Developed Markets ETF in Q1 2022, an estimated $10.3M increase.
  • Arlington Partners's biggest Q1 2022 reduction was iShares Emerging Markets Dividend ETF, cutting an estimated $8.36M.
  • Arlington Partners fully exited iShares Gold Trust in Q1 2022, selling an estimated $1.2M.
  • Arlington Partners's ten largest holdings make up 58% of its $353M portfolio in Q1 2022.
  • Arlington Partners opened 19 new positions and closed 246 in Q1 2022.
  • Arlington Partners's portfolio value fell 5.1% quarter-over-quarter to $353M.

Based on Arlington Partners's 13F filing for Q1 2022, filed 14 Apr 2022.